EUCI — Eurocine Vaccines AB Share Price
0.000.00%
Last trade - 00:00- SEK5.85m
- SEK4.54m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1,171 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -323.22% | ||
| Operating Margin | -301600% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Eurocine Vaccines AB is a Sweden-based clinical-stage company, which develops nasal vaccines. The Company develops vaccines up to proof of concept (clinical phase I/II) and license to partners for further development and commercialization. Also, the Company offers license partners vaccine adjuvant technologies, which are a key element of the nasal vaccines, for development in various indications. For these purposes the Company’s uses its clinically validated technology Endocine. In addition, the Company’s primary project is the nasal quadrivalent influenza vaccine Immunos FLU that aims for children from six month. The Company cooperates with both academic researchers and contract businesses and owns all income generated in these collaborations.
Directors
- Pierre Morgon CHM (57)
- Hans Arwidsson PRE (63)
- Karl Ljungberg OTH
- Emanuele Montomoli DRC
- Jan Sandstrom DRC (78)
- Par Thuresson DRC (57)
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 15th, 1999
- Public Since
- December 12th, 2006
- No. of Employees
- 3
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 344,410,497
- Address
- Nanna Svartz vag 4, SOLNA, 171 65
- Web
- https://www.eurocine-vaccines.com/
- Phone
- +46 850884592
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for EUCI
Q4 2024 Eurocine Vaccines AB Earnings Release
Similar to EUCI
Abera Bioscience AB
AktieTorget Stock Exchange
Aptahem AB
AktieTorget Stock Exchange
Arcede Pharma AB
AktieTorget Stock Exchange
Carbiotix AB (publ)
AktieTorget Stock Exchange
Chosa Oncology AB
AktieTorget Stock Exchange
FAQ
What is the Eurocine Vaccines AB share price?
As of Today at 19:08 UTC, shares in Eurocine Vaccines AB are trading at SEK0.02. This share price information is delayed by 15 minutes.
How has the Eurocine Vaccines AB share price performed this year?
Shares in Eurocine Vaccines AB last closed at SEK0.02 and the price had moved by -94.97% over the past 365 days. In terms of relative price strength the Eurocine Vaccines AB share price has underperformed the FTSE Global All Cap Index by -95.36% over the past year.
What are the analyst and broker recommendations for Eurocine Vaccines AB?
There is no consensus recommendation for this security.
What is the Eurocine Vaccines AB dividend yield?
Eurocine Vaccines AB does not currently pay a dividend.
Does Eurocine Vaccines AB pay a dividend?
Eurocine Vaccines AB does not currently pay a dividend.
When does Eurocine Vaccines AB next pay dividends?
Eurocine Vaccines AB does not currently pay a dividend.
How do I buy Eurocine Vaccines AB shares?
To buy shares in Eurocine Vaccines AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Eurocine Vaccines AB?
As of the previous close price of SEK0.02, shares in Eurocine Vaccines AB had a market capitalisation of SEK5.85m.
Where are Eurocine Vaccines AB shares listed?
Here are the trading details for Eurocine Vaccines AB:
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: EUCI
What kind of share is Eurocine Vaccines AB?
Based on an overall assessment of its quality, value and momentum Eurocine Vaccines AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Eurocine Vaccines AB share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Eurocine Vaccines AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eurocine Vaccines AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -63.29%.
As of the last closing price of SEK0.02, shares in Eurocine Vaccines AB were trading -75.46% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Eurocine Vaccines AB PE Ratio?
The Eurocine Vaccines AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Eurocine Vaccines AB?
Eurocine Vaccines AB's management team is headed by:
- Pierre Morgon - CHM
- Hans Arwidsson - PRE
- Karl Ljungberg - OTH
- Emanuele Montomoli - DRC
- Jan Sandstrom - DRC
- Par Thuresson - DRC